240 related articles for article (PubMed ID: 16760190)
1. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Pisa P; Lax I; Kälkner KM; Svedman C
Acta Oncol; 2006; 45(4):493-7. PubMed ID: 16760190
[No Abstract] [Full Text] [Related]
2. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Lax I; Kälkner KM; Linder C; Lundell G; Nilsson B; Nilsson S; Näslund I; Pisa P; Svedman C
Radiother Oncol; 2005 Oct; 77(1):88-95. PubMed ID: 15972239
[TBL] [Abstract][Full Text] [Related]
3. [Results of radiotherapy of hypernephroma metastases].
Schertel L; Mohring R; Brameyer I
Rontgenpraxis; 1989 Mar; 42(3):93-8. PubMed ID: 2705084
[No Abstract] [Full Text] [Related]
4. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Svedman C; Karlsson K; Rutkowska E; Sandström P; Blomgren H; Lax I; Wersäll P
Acta Oncol; 2008; 47(8):1578-83. PubMed ID: 18607859
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy to bone has utility in multifocal metastatic renal carcinoma.
Reichel LM; Pohar S; Heiner J; Buzaianu EM; Damron TA
Clin Orthop Relat Res; 2007 Jun; 459():133-8. PubMed ID: 17438472
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of metastatic renal cell carcinoma.
Seitz W; Kärcher KH; Binder W
Semin Surg Oncol; 1988; 4(2):100-2. PubMed ID: 3134686
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
11. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
[TBL] [Abstract][Full Text] [Related]
12. Radiodermatitis following kidney cancer radiotherapy.
Gravante G; Delogu D; Esposito G; Montone A
Eur Rev Med Pharmacol Sci; 2006; 10(6):346. PubMed ID: 17274538
[No Abstract] [Full Text] [Related]
13. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
14. Solitary, late metastatic recurrence of renal cell carcinoma: two extraordinary cases.
Featherstone JM; Bass P; Cumming J; Smart CJ
Int J Urol; 2006 Dec; 13(12):1525-7. PubMed ID: 17118029
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.
Ng AW; Tung SY; Wong VY
Radiother Oncol; 2008 Apr; 87(1):24-8. PubMed ID: 18334273
[TBL] [Abstract][Full Text] [Related]
16. [Radiation therapy for bone metastasis from renal cell carcinoma with emphasis on local control].
Hatano T; Suzuki K; Nagashima A; Yamaguchi Y; Sanuki K; Kishimoto K; Sunagawa Y; Harada J; Egawa S
Hinyokika Kiyo; 2007 Oct; 53(10):687-90. PubMed ID: 18018582
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell carcinoma to the mandible.
Sastre J; Naval L; Muñoz M; Gamallo C; Diaz FJ
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):663-4. PubMed ID: 15806067
[No Abstract] [Full Text] [Related]
18. Stereotactic boost irradiation for targets in the abdomen and pelvis.
Wulf J; Hädinger U; Oppitz U; Thiele W; Flentje M
Radiother Oncol; 2004 Jan; 70(1):31-6. PubMed ID: 15036849
[TBL] [Abstract][Full Text] [Related]
19. [Radiochemotherapy in the treatment of metastatic renal cell carcinoma].
Strnad V; Senft M
Strahlenther Onkol; 1993 Dec; 169(12):745-7. PubMed ID: 8284748
[TBL] [Abstract][Full Text] [Related]
20. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.
Gay HA; Cavalieri R; Allison RR; Finley J; Quan WD
Dermatol Online J; 2007 Oct; 13(4):6. PubMed ID: 18319003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
